Tecovirimat is Safe But Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congo
Tecovirimat did not improve clade I mpox resolution in DRC, but showed safe use and lower mortality. Ongoing trials like PALM007 and STOMP aim to develop effective mpox interventions.
Related Clinical Trials
Highlighted Terms
NCT05597735Kinshasa University Medical SchoolNCT05559099Leidos Biomedical ResearchFood and Drug AdministrationInstitut National de Recherche BiomédicaleWorld Health OrganizationNCT05534984Institute of Tropical Medicine AntwerpAlliance for International Medical ActionFrederick National Laboratory for Cancer ResearchDemocratic Republic of the CongoTecovirimatmpoxCenters for Disease Control and PreventionU.S. Department of Health and Human ServicesNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthSIGA Technologies, Inc.
Related News
Tecovirimat is Safe But Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congo
Tecovirimat did not improve clade I mpox resolution in DRC, but showed safe use and lower mortality. Ongoing trials like PALM007 and STOMP aim to develop effective mpox interventions.